The IRA is changing what “good” looks like in negotiation readiness. Evidence, value articulation, and cross-functional decision-making have to be designed years ahead, not assembled after selection.
FirstWord’s ExpertViews report, The Future Impact of the Inflation Reduction Act on Pharma Drug Pricing, brings together a small set of ecosystem perspectives. Lumanity’s Leeann Lui was interviewed as one of the contributing experts.
Read the full report via FirstWord.
For more on how Lumanity supports time-sensitive IRA submissions and negotiation readiness through coordinated, cross-functional planning, visit our IRA page.
